Clinical Trial: Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)

U.S., Feb. 13 -- ClinicalTrials.gov registry received information related to the study (NCT06821958) titled 'Amplitude-modulated Radiofrequency Electromagnetic Field Treatment for Advanced Hepatocellular Carcinoma (Immune-RF)' on Dec. 21, 2024.

Brief Summary: Combined double immune checkpoint inhibition and radiofrequency electromagnetic field treatment for patients with advanced hepatocellular carcinoma

Study Start Date: March 01

Study Type: INTERVENTIONAL

Condition: Hepatocellular Carcinoma (HCC)

Intervention: DEVICE: Radiofrequency electromagnetic field treatment

Radiofrequency electromagnetic field treatment using a carrier frequency of 13.56 MHz

Recruitment Status: RECRUITING

Sponsor: Charite University, Berlin, Germany

Info...